SIRT1 and breast cancer: For example, in HMLER breast cancer cells, reduced SIRT1 levels are associated with increased metastases 10, whilst high SIRT1 expression promoted tumorigenesis and is associated with poor prognosis in colorectal carcinoma patients 11.